ATLASGilead Sciences (GILD) earnings date: expected January 20–26
Gilead Sciences (GILD) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 20–26. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on GILD
| Last price | $170.68 (+3.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.7% |
| Earnings beat history | Beat the EPS estimate in 6 of the last 6 reports |
| Dividend | $3.25 a year (1.90% yield) · next ex-date Dec 15, 2026 |
These figures come from the same calibrated model and valuation as the Gilead Sciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 20–26 (estimate). One email the day before, with ATLAS’s read on Gilead Sciences. You can switch it off at any time.
Alert me before GILD reportsFree to start. Creating an account takes under a minute.
GILD earnings at a glance
| Next report | Not announced · expected around January 20–26 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 6 of 6 (100%) |
| Average EPS surprise | +23.5% |
| Average move around a report | ±1.8% (last 5) |
| Sector | Healthcare · Drug Manufacturers - General |
The expected window is an ATLAS estimate: it takes the typical gap between Gilead Sciences’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Gilead Sciences earnings history: last 6 reports
Gilead Sciences last reported on Oct 29, 2026: EPS of $2.55 against an estimate of $2.17 (+17.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $2.17 | $2.55 | +17.5% | Beat | – |
| Aug 4, 2026 | -$7.25 | -$6.75 | +6.9% | Beat | +0.5% |
| May 7, 2026 | $1.91 | $2.03 | +6.3% | Beat | -3.7% |
| Feb 10, 2026 | $1.81 | $1.86 | +2.8% | Beat | +2.7% |
| Oct 30, 2025 | $2.14 | $2.47 | +15.4% | Beat | +1.1% |
| Sep 23, 2025 | $1.23 | $2.36 | +91.9% | Beat | +1.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for GILD
See the fair value, the probability range and the earnings history of Gilead Sciences on its ATLAS page.
Gilead Sciences (GILD) stock analysisPlans from €3.99 a month.
Gilead Sciences earnings: frequently asked questions
When is Gilead Sciences (GILD) next earnings date?
Gilead Sciences has not announced its next report. Its last 4 reports came Oct 29, 2026, Aug 4, 2026, May 7, 2026, Feb 10, 2026, so ATLAS estimates the next one around January 20–26. This is an estimate based on that pattern, not a confirmed date.
How often does GILD beat earnings estimates?
Of its last 6 reports with a recorded result, Gilead Sciences beat the EPS estimate 6 times; the average surprise was +23.5%. Past results do not predict the next one.
How much does GILD move around earnings?
Over its last 5 reports the stock moved an average of 1.8% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Gilead Sciences beat earnings estimates last quarter?
Gilead Sciences last reported on Oct 29, 2026: EPS of $2.55 against an estimate of $2.17 (+17.5% surprise), a beat.
How much does GILD usually move in a day?
On a normal trading day the ATLAS model puts GILD’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer